RedHill Biopharma reported $89.8K in Interest Expense on Debt for its fiscal quarter ending in June of 2024.





Interest Expense On Debt Change Date
Compugen USD 954K 116K Sep/2025
Cronos Group USD 0 7K Sep/2024
RedHill Biopharma USD 89.8K 31.69M Jun/2024